Skip to main content
Premium Trial:

Request an Annual Quote

MedGenome Completes $40M Series C Funding With HFDC Investment

NEW YORK (GenomeWeb) – MedGenome has completed a $40 million Series C fundraising round with an investment by Indian financial services companies HDFC, HDFC Life, and HDFC Asset Management, adding $10 million to $30 million the company raised in its Series C round last year.

The genomic diagnostics and research firm plans to use the new investment to expand its clinical genomic testing business in India, particularly for noninvasive prenatal screening and newborn genetic testing, by  establishing more genetic centers in hospitals across the country.

"We believe understanding genetic information can have a big impact on [the] Indian healthcare industry through early detection of disease risk and development of new medicines," Deepak Parekh, chairman of HDFC Group, said in a statement.

Sam Santhosh, founder and chairman of MedGenome, added: "MedGenome's goal is to significantly reduce the burden of inherited diseases in India and assist clinicians in implementing precision medicine."

MedGenome has next-generation sequencing laboratories in Bangalore, India; Foster City, California; and Singapore. It runs its clinical diagnostic tests primarily from its Bangalore lab, while its research projects are conducted mainly in the Foster City location.

Last year, it launched a liquid biopsy test for colorectal cancer, melanoma, and lung cancer patients. The test analyzes mutations in EGFR, KRAS, NRAS, and BRAF. In addition, it offers Natera's NIPT, as well as rare disease testing via single-gene, NGS gene panels, and exome sequencing.

Last month, Santhosh said it planned to ramp up research in the single-cell and immuno-oncology spaces.

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.